Impact of Mixed Reality Training on Motor Skills in Children With Autistic Spectrum Disorder

NCT ID: NCT05302544

Last Updated: 2022-04-27

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

44 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-05-15

Study Completion Date

2023-05-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

People with autistic spectrum disorder frequently present impaired motricity, or at least different motricity from neurotypical subjects (walking; postural balance; fine motor skills; motor control, etc.). Motor impairment can have impact on the performance and learning of simple tasks (bathing, dressing, writing, using tools, etc.), especially in children and teenagers.

These last years, new therapeutics such as Virtual, Augmented and Mixed Reality technologies have developed. Their therapeutic interest has been identified in various pathologies like phobia. However, their influence on motor skills has been little studied. The first results obtained with disabled adults described a significant increase in walking speed after a 3-month Mixed Reality training.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The aim of the study is to assess the impact of Mixed Reality training on motor skills of children with autistic spectrum disorder.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Autistic Spectrum Disorder

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

"with mixed reality training" group

2 Mixed Reality sessions per week for 8 weeks in addition to motor activities usually performed

Group Type EXPERIMENTAL

Mixed Reality training

Intervention Type OTHER

Mixed Reality training: Mixed Reality game with appearance of virtual balloons in the game area that the subject must find and pierce with finger

motor activities

Intervention Type OTHER

motor activities usually performed

"without mixed reality training" group

group: only motor activities usually performed

Group Type ACTIVE_COMPARATOR

motor activities

Intervention Type OTHER

motor activities usually performed

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Mixed Reality training

Mixed Reality training: Mixed Reality game with appearance of virtual balloons in the game area that the subject must find and pierce with finger

Intervention Type OTHER

motor activities

motor activities usually performed

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* aged between 8 and 12 years old
* with autistic spectrum disorder
* male or female
* agreeing to participate in the study

Exclusion Criteria

* Visually impaired or blind.
* Traumatism and physical injuries
* Epilepsy
Minimum Eligible Age

8 Years

Maximum Eligible Age

12 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Université de Reims Champagne-Ardenne

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Nicolas HOUEL, MCU-PhD

Role: CONTACT

0326918822 ext. +33

Coralie BARBE, MD

Role: CONTACT

0326918822 ext. +33

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2022_RIPH_001_RAMAu

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.